US Broker Ratings

Galapagos NV (GLPG) Stock Analysis: Understanding the Biotechnology Stock’s Potential Amid Revenue Growth and Analyst Ratings

Investors with an eye on the biotechnology sector may find Galapagos NV (NASDAQ: GLPG) an intriguing company to consider. While the company’s share price recently closed at $33.52, representing a..

Kiniksa Pharmaceuticals, Ltd. (KNSA)

⚠️ No article content returned.

..

CRISPR Therapeutics AG (CRSP)

⚠️ No article content returned.

..

QuidelOrtho Corporation (QDEL) Stock Analysis: Evaluating a 13.45% Potential Upside in the Healthcare Sector

QuidelOrtho Corporation (NASDAQ: QDEL), a prominent player in the healthcare sector specializing in medical devices, presents a compelling opportunity for investors seeking exposure to diagnostic testing solutions. With a market..

Surgery Partners, Inc. (SGRY) Stock Analysis: Unraveling a 60% Upside Potential

Surgery Partners, Inc. (SGRY), a key player in the healthcare sector, specifically in the medical care facilities industry, presents a compelling investment opportunity with a potential upside of 60.09%. This..

Belite Bio, Inc (BLTE) Stock Analysis: A Clinical Stage Biotech with a 19.45% Upside Potential

Belite Bio, Inc (BLTE), a promising player in the biotechnology sector, is drawing attention with its ambitious drug development pipeline and favorable analyst ratings. As the company advances its clinical..

Scholar Rock Holding Corporation (SRRK) Stock Analysis: A Biotech with 9.76% Potential Upside

Scholar Rock Holding Corporation (NASDAQ: SRRK) is making waves in the biotechnology sector, capturing investor attention with its promising pipeline of innovative treatments focused on serious diseases. With a current..

NovoCure Limited (NVCR): Investor Outlook on a 76% Potential Upside in Medical Device Innovation

NovoCure Limited (NASDAQ: NVCR), a notable player in the healthcare sector, is carving a niche in the medical devices industry with its innovative tumor treating fields (TTFields) technology. Headquartered in..

Immunovant, Inc. (IMVT) Stock Analysis: A Biotech Marvel with 53% Potential Upside

Immunovant, Inc. (NASDAQ: IMVT), an intriguing player in the biotechnology sector, is capturing investor attention with its promising portfolio of monoclonal antibodies targeting autoimmune diseases. With a substantial market capitalization..

Crinetics Pharmaceuticals, Inc. (CRNX) Investor Outlook: Analyzing a Promising 50.92% Potential Upside

Crinetics Pharmaceuticals, Inc. (CRNX), a pivotal player in the biotechnology sector, is drawing significant attention from investors with its robust pipeline targeting rare endocrine diseases. The San Diego-based company is..

Apellis Pharmaceuticals, Inc. (APLS) Stock Analysis: Potential 74% Upside as Revenue Surges

Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) has become a focal point for investors in the biotechnology sector, not just because of its innovative approach to meeting unmet medical needs, but also..

ImmunityBio, Inc. (IBRX) Investor Outlook: Exploring a 95.65% Potential Upside in the Biotechnology Sector

In the ever-evolving landscape of biotechnology, ImmunityBio, Inc. (NASDAQ: IBRX) stands as a noteworthy player with significant growth potential. With a market capitalization of $5.44 billion, this San Diego-based biotech..

Alignment Healthcare, Inc. (ALHC) Stock Analysis: Exploring Growth Potential and Analyst Ratings

Alignment Healthcare, Inc. (NASDAQ: ALHC) is carving a niche in the healthcare sector with its innovative approach to senior care through Medicare Advantage plans. With a market capitalization of $4.5..

Viking Therapeutics, Inc. (VKTX) Investor Outlook: A Biotech Stock with 175% Potential Upside

Viking Therapeutics, Inc. (NASDAQ: VKTX) is garnering significant attention in the biotech sector, primarily due to its promising drug pipeline and an impressive potential upside of 175.38%, according to recent..

Privia Health Group, Inc. (PRVA) Investor Outlook: Revenue Growth Sparks a 34% Upside Potential

Privia Health Group, Inc. (NASDAQ: PRVA) is garnering attention as a noteworthy player in the healthcare sector, specifically in the health information services industry. With a market capitalization of $2.87..

DENTSPLY SIRONA Inc. (XRAY) Stock Analysis: Navigating the Challenges with an Attractive 5.24% Dividend Yield

DENTSPLY SIRONA Inc. (NASDAQ: XRAY), a prominent player in the healthcare sector, is facing a complex landscape marked by both challenges and opportunities. With a market capitalization of $2.44 billion,..

Acadia Healthcare Company, Inc. (ACHC) Stock Analysis: Unpacking a Potential 74.90% Upside

Investors looking for opportunities in the healthcare sector might want to consider Acadia Healthcare Company, Inc. (NASDAQ: ACHC), a key player in the medical care facilities industry. Headquartered in Franklin,..

MoonLake Immunotherapeutics (MLTX) Stock Analysis: Exploring a Biotech Innovator’s Growth Potential with an 11% Upside

MoonLake Immunotherapeutics (NASDAQ: MLTX), a Swiss-based biotechnology firm, is capturing investor attention with its focus on developing innovative treatments for inflammatory skin and joint diseases. The company, founded in 2021..

ICU Medical, Inc. (ICUI) Stock Analysis: Exploring a 15.79% Upside in the Healthcare Sector

ICU Medical, Inc. (NASDAQ: ICUI), a key player in the healthcare sector, is capturing investor attention with its significant potential upside of 15.79%. With a market capitalization of $3.86 billion,..

Amneal Pharmaceuticals, Inc. (AMRX) Stock Analysis: Eyeing a Strategic Upside with a 7.38% Potential

Amneal Pharmaceuticals, Inc. (NYSE: AMRX), a prominent player in the healthcare sector, specializes in developing and distributing a diverse range of pharmaceutical products. With its market capitalization standing at an..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds